Global Interventional Ventricular Assist Devices Market Growth 2026-2032
The global Interventional Ventricular Assist Devices market size is predicted to grow from US$ 1787 million in 2025 to US$ 4028 million in 2032; it is expected to grow at a CAGR of 12.6% from 2026 to 2032.
Interventional Ventricular Assist Devices are minimally invasive cardiac assist devices designed to provide temporary circulatory support during cardiac surgery or the treatment of acute heart failure. These systems, implanted through sophisticated interventional procedures, are capable of assisting pumping blood in or around the heart to maintain blood circulation, buying patients time to recover or serving as a bridge to long-term treatment. The operation of IVADs relies on an external power supply and control unit, which can be rapidly deployed to provide immediate hemodynamic support to the patient.
United States market for Interventional Ventricular Assist Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Interventional Ventricular Assist Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Interventional Ventricular Assist Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Interventional Ventricular Assist Devices players cover Abiomed, Inc., LivaNova, Inc, Levitronix, HeartWare International Pty Ltd, PulseCath, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Interventional Ventricular Assist Devices Industry Forecast? looks at past sales and reviews total world Interventional Ventricular Assist Devices sales in 2025, providing a comprehensive analysis by region and market sector of projected Interventional Ventricular Assist Devices sales for 2026 through 2032. With Interventional Ventricular Assist Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Ventricular Assist Devices industry.
This Insight Report provides a comprehensive analysis of the global Interventional Ventricular Assist Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interventional Ventricular Assist Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Interventional Ventricular Assist Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Ventricular Assist Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Ventricular Assist Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Ventricular Assist Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Interventional Ventricular Assist Devices market?
What factors are driving Interventional Ventricular Assist Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Interventional Ventricular Assist Devices market opportunities vary by end market size?
How does Interventional Ventricular Assist Devices break out by Type, by Application?
Interventional Ventricular Assist Devices are minimally invasive cardiac assist devices designed to provide temporary circulatory support during cardiac surgery or the treatment of acute heart failure. These systems, implanted through sophisticated interventional procedures, are capable of assisting pumping blood in or around the heart to maintain blood circulation, buying patients time to recover or serving as a bridge to long-term treatment. The operation of IVADs relies on an external power supply and control unit, which can be rapidly deployed to provide immediate hemodynamic support to the patient.
United States market for Interventional Ventricular Assist Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Interventional Ventricular Assist Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Interventional Ventricular Assist Devices is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Interventional Ventricular Assist Devices players cover Abiomed, Inc., LivaNova, Inc, Levitronix, HeartWare International Pty Ltd, PulseCath, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Interventional Ventricular Assist Devices Industry Forecast? looks at past sales and reviews total world Interventional Ventricular Assist Devices sales in 2025, providing a comprehensive analysis by region and market sector of projected Interventional Ventricular Assist Devices sales for 2026 through 2032. With Interventional Ventricular Assist Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Interventional Ventricular Assist Devices industry.
This Insight Report provides a comprehensive analysis of the global Interventional Ventricular Assist Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Interventional Ventricular Assist Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Interventional Ventricular Assist Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Interventional Ventricular Assist Devices and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Interventional Ventricular Assist Devices.
This report presents a comprehensive overview, market shares, and growth opportunities of Interventional Ventricular Assist Devices market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 2.5L/min
- 3.5L/min
- 5.0L/min
- 5.5L/min
- Public Hospitals
- Private Hospital
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Abiomed, Inc.
- LivaNova, Inc
- Levitronix
- HeartWare International Pty Ltd
- PulseCath
- Magenta Medical
- Shenzhen Hanuo Medical Technology Co., Ltd
- Shanghai Newmed Medical Technology Co., Ltd
What is the 10-year outlook for the global Interventional Ventricular Assist Devices market?
What factors are driving Interventional Ventricular Assist Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Interventional Ventricular Assist Devices market opportunities vary by end market size?
How does Interventional Ventricular Assist Devices break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Interventional Ventricular Assist Devices Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Interventional Ventricular Assist Devices by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Interventional Ventricular Assist Devices by Country/Region, 2021, 2025 & 2032
2.2 Interventional Ventricular Assist Devices Segment by Type
2.2.1 2.5L/min
2.2.2 3.5L/min
2.2.3 5.0L/min
2.2.4 5.5L/min
2.2.5 Interventional Ventricular Assist Devices Sales by Type
2.2.5.1 Global Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
2.2.5.2 Global Interventional Ventricular Assist Devices Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Interventional Ventricular Assist Devices Sale Price by Type (2021-2026)
2.3 Interventional Ventricular Assist Devices Segment by Application
2.3.1 Public Hospitals
2.3.2 Private Hospital
2.3.3 Interventional Ventricular Assist Devices Sales by Application
2.3.3.1 Global Interventional Ventricular Assist Devices Sale Market Share by Application (2021-2026)
2.3.3.2 Global Interventional Ventricular Assist Devices Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Interventional Ventricular Assist Devices Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Interventional Ventricular Assist Devices Breakdown Data by Company
3.1.1 Global Interventional Ventricular Assist Devices Annual Sales by Company (2021-2026)
3.1.2 Global Interventional Ventricular Assist Devices Sales Market Share by Company (2021-2026)
3.2 Global Interventional Ventricular Assist Devices Annual Revenue by Company (2021-2026)
3.2.1 Global Interventional Ventricular Assist Devices Revenue by Company (2021-2026)
3.2.2 Global Interventional Ventricular Assist Devices Revenue Market Share by Company (2021-2026)
3.3 Global Interventional Ventricular Assist Devices Sale Price by Company
3.4 Key Manufacturers Interventional Ventricular Assist Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Interventional Ventricular Assist Devices Product Location Distribution
3.4.2 Players Interventional Ventricular Assist Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTERVENTIONAL VENTRICULAR ASSIST DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Interventional Ventricular Assist Devices Market Size by Geographic Region (2021-2026)
4.1.1 Global Interventional Ventricular Assist Devices Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Interventional Ventricular Assist Devices Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Interventional Ventricular Assist Devices Market Size by Country/Region (2021-2026)
4.2.1 Global Interventional Ventricular Assist Devices Annual Sales by Country/Region (2021-2026)
4.2.2 Global Interventional Ventricular Assist Devices Annual Revenue by Country/Region (2021-2026)
4.3 Americas Interventional Ventricular Assist Devices Sales Growth
4.4 APAC Interventional Ventricular Assist Devices Sales Growth
4.5 Europe Interventional Ventricular Assist Devices Sales Growth
4.6 Middle East & Africa Interventional Ventricular Assist Devices Sales Growth
5 AMERICAS
5.1 Americas Interventional Ventricular Assist Devices Sales by Country
5.1.1 Americas Interventional Ventricular Assist Devices Sales by Country (2021-2026)
5.1.2 Americas Interventional Ventricular Assist Devices Revenue by Country (2021-2026)
5.2 Americas Interventional Ventricular Assist Devices Sales by Type (2021-2026)
5.3 Americas Interventional Ventricular Assist Devices Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interventional Ventricular Assist Devices Sales by Region
6.1.1 APAC Interventional Ventricular Assist Devices Sales by Region (2021-2026)
6.1.2 APAC Interventional Ventricular Assist Devices Revenue by Region (2021-2026)
6.2 APAC Interventional Ventricular Assist Devices Sales by Type (2021-2026)
6.3 APAC Interventional Ventricular Assist Devices Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Interventional Ventricular Assist Devices by Country
7.1.1 Europe Interventional Ventricular Assist Devices Sales by Country (2021-2026)
7.1.2 Europe Interventional Ventricular Assist Devices Revenue by Country (2021-2026)
7.2 Europe Interventional Ventricular Assist Devices Sales by Type (2021-2026)
7.3 Europe Interventional Ventricular Assist Devices Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Interventional Ventricular Assist Devices by Country
8.1.1 Middle East & Africa Interventional Ventricular Assist Devices Sales by Country (2021-2026)
8.1.2 Middle East & Africa Interventional Ventricular Assist Devices Revenue by Country (2021-2026)
8.2 Middle East & Africa Interventional Ventricular Assist Devices Sales by Type (2021-2026)
8.3 Middle East & Africa Interventional Ventricular Assist Devices Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Interventional Ventricular Assist Devices
10.3 Manufacturing Process Analysis of Interventional Ventricular Assist Devices
10.4 Industry Chain Structure of Interventional Ventricular Assist Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Interventional Ventricular Assist Devices Distributors
11.3 Interventional Ventricular Assist Devices Customer
12 WORLD FORECAST REVIEW FOR INTERVENTIONAL VENTRICULAR ASSIST DEVICES BY GEOGRAPHIC REGION
12.1 Global Interventional Ventricular Assist Devices Market Size Forecast by Region
12.1.1 Global Interventional Ventricular Assist Devices Forecast by Region (2027-2032)
12.1.2 Global Interventional Ventricular Assist Devices Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Interventional Ventricular Assist Devices Forecast by Type (2027-2032)
12.7 Global Interventional Ventricular Assist Devices Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Abiomed, Inc.
13.1.1 Abiomed, Inc. Company Information
13.1.2 Abiomed, Inc. Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.1.3 Abiomed, Inc. Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Abiomed, Inc. Main Business Overview
13.1.5 Abiomed, Inc. Latest Developments
13.2 LivaNova, Inc
13.2.1 LivaNova, Inc Company Information
13.2.2 LivaNova, Inc Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.2.3 LivaNova, Inc Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 LivaNova, Inc Main Business Overview
13.2.5 LivaNova, Inc Latest Developments
13.3 Levitronix
13.3.1 Levitronix Company Information
13.3.2 Levitronix Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.3.3 Levitronix Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Levitronix Main Business Overview
13.3.5 Levitronix Latest Developments
13.4 HeartWare International Pty Ltd
13.4.1 HeartWare International Pty Ltd Company Information
13.4.2 HeartWare International Pty Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.4.3 HeartWare International Pty Ltd Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 HeartWare International Pty Ltd Main Business Overview
13.4.5 HeartWare International Pty Ltd Latest Developments
13.5 PulseCath
13.5.1 PulseCath Company Information
13.5.2 PulseCath Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.5.3 PulseCath Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 PulseCath Main Business Overview
13.5.5 PulseCath Latest Developments
13.6 Magenta Medical
13.6.1 Magenta Medical Company Information
13.6.2 Magenta Medical Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.6.3 Magenta Medical Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Magenta Medical Main Business Overview
13.6.5 Magenta Medical Latest Developments
13.7 Shenzhen Hanuo Medical Technology Co., Ltd
13.7.1 Shenzhen Hanuo Medical Technology Co., Ltd Company Information
13.7.2 Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.7.3 Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shenzhen Hanuo Medical Technology Co., Ltd Main Business Overview
13.7.5 Shenzhen Hanuo Medical Technology Co., Ltd Latest Developments
13.8 Shanghai Newmed Medical Technology Co., Ltd
13.8.1 Shanghai Newmed Medical Technology Co., Ltd Company Information
13.8.2 Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.8.3 Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanghai Newmed Medical Technology Co., Ltd Main Business Overview
13.8.5 Shanghai Newmed Medical Technology Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Interventional Ventricular Assist Devices Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Interventional Ventricular Assist Devices by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Interventional Ventricular Assist Devices by Country/Region, 2021, 2025 & 2032
2.2 Interventional Ventricular Assist Devices Segment by Type
2.2.1 2.5L/min
2.2.2 3.5L/min
2.2.3 5.0L/min
2.2.4 5.5L/min
2.2.5 Interventional Ventricular Assist Devices Sales by Type
2.2.5.1 Global Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
2.2.5.2 Global Interventional Ventricular Assist Devices Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Interventional Ventricular Assist Devices Sale Price by Type (2021-2026)
2.3 Interventional Ventricular Assist Devices Segment by Application
2.3.1 Public Hospitals
2.3.2 Private Hospital
2.3.3 Interventional Ventricular Assist Devices Sales by Application
2.3.3.1 Global Interventional Ventricular Assist Devices Sale Market Share by Application (2021-2026)
2.3.3.2 Global Interventional Ventricular Assist Devices Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Interventional Ventricular Assist Devices Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Interventional Ventricular Assist Devices Breakdown Data by Company
3.1.1 Global Interventional Ventricular Assist Devices Annual Sales by Company (2021-2026)
3.1.2 Global Interventional Ventricular Assist Devices Sales Market Share by Company (2021-2026)
3.2 Global Interventional Ventricular Assist Devices Annual Revenue by Company (2021-2026)
3.2.1 Global Interventional Ventricular Assist Devices Revenue by Company (2021-2026)
3.2.2 Global Interventional Ventricular Assist Devices Revenue Market Share by Company (2021-2026)
3.3 Global Interventional Ventricular Assist Devices Sale Price by Company
3.4 Key Manufacturers Interventional Ventricular Assist Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Interventional Ventricular Assist Devices Product Location Distribution
3.4.2 Players Interventional Ventricular Assist Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR INTERVENTIONAL VENTRICULAR ASSIST DEVICES BY GEOGRAPHIC REGION
4.1 World Historic Interventional Ventricular Assist Devices Market Size by Geographic Region (2021-2026)
4.1.1 Global Interventional Ventricular Assist Devices Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Interventional Ventricular Assist Devices Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Interventional Ventricular Assist Devices Market Size by Country/Region (2021-2026)
4.2.1 Global Interventional Ventricular Assist Devices Annual Sales by Country/Region (2021-2026)
4.2.2 Global Interventional Ventricular Assist Devices Annual Revenue by Country/Region (2021-2026)
4.3 Americas Interventional Ventricular Assist Devices Sales Growth
4.4 APAC Interventional Ventricular Assist Devices Sales Growth
4.5 Europe Interventional Ventricular Assist Devices Sales Growth
4.6 Middle East & Africa Interventional Ventricular Assist Devices Sales Growth
5 AMERICAS
5.1 Americas Interventional Ventricular Assist Devices Sales by Country
5.1.1 Americas Interventional Ventricular Assist Devices Sales by Country (2021-2026)
5.1.2 Americas Interventional Ventricular Assist Devices Revenue by Country (2021-2026)
5.2 Americas Interventional Ventricular Assist Devices Sales by Type (2021-2026)
5.3 Americas Interventional Ventricular Assist Devices Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Interventional Ventricular Assist Devices Sales by Region
6.1.1 APAC Interventional Ventricular Assist Devices Sales by Region (2021-2026)
6.1.2 APAC Interventional Ventricular Assist Devices Revenue by Region (2021-2026)
6.2 APAC Interventional Ventricular Assist Devices Sales by Type (2021-2026)
6.3 APAC Interventional Ventricular Assist Devices Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Interventional Ventricular Assist Devices by Country
7.1.1 Europe Interventional Ventricular Assist Devices Sales by Country (2021-2026)
7.1.2 Europe Interventional Ventricular Assist Devices Revenue by Country (2021-2026)
7.2 Europe Interventional Ventricular Assist Devices Sales by Type (2021-2026)
7.3 Europe Interventional Ventricular Assist Devices Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Interventional Ventricular Assist Devices by Country
8.1.1 Middle East & Africa Interventional Ventricular Assist Devices Sales by Country (2021-2026)
8.1.2 Middle East & Africa Interventional Ventricular Assist Devices Revenue by Country (2021-2026)
8.2 Middle East & Africa Interventional Ventricular Assist Devices Sales by Type (2021-2026)
8.3 Middle East & Africa Interventional Ventricular Assist Devices Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Interventional Ventricular Assist Devices
10.3 Manufacturing Process Analysis of Interventional Ventricular Assist Devices
10.4 Industry Chain Structure of Interventional Ventricular Assist Devices
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Interventional Ventricular Assist Devices Distributors
11.3 Interventional Ventricular Assist Devices Customer
12 WORLD FORECAST REVIEW FOR INTERVENTIONAL VENTRICULAR ASSIST DEVICES BY GEOGRAPHIC REGION
12.1 Global Interventional Ventricular Assist Devices Market Size Forecast by Region
12.1.1 Global Interventional Ventricular Assist Devices Forecast by Region (2027-2032)
12.1.2 Global Interventional Ventricular Assist Devices Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Interventional Ventricular Assist Devices Forecast by Type (2027-2032)
12.7 Global Interventional Ventricular Assist Devices Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Abiomed, Inc.
13.1.1 Abiomed, Inc. Company Information
13.1.2 Abiomed, Inc. Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.1.3 Abiomed, Inc. Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Abiomed, Inc. Main Business Overview
13.1.5 Abiomed, Inc. Latest Developments
13.2 LivaNova, Inc
13.2.1 LivaNova, Inc Company Information
13.2.2 LivaNova, Inc Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.2.3 LivaNova, Inc Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 LivaNova, Inc Main Business Overview
13.2.5 LivaNova, Inc Latest Developments
13.3 Levitronix
13.3.1 Levitronix Company Information
13.3.2 Levitronix Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.3.3 Levitronix Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Levitronix Main Business Overview
13.3.5 Levitronix Latest Developments
13.4 HeartWare International Pty Ltd
13.4.1 HeartWare International Pty Ltd Company Information
13.4.2 HeartWare International Pty Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.4.3 HeartWare International Pty Ltd Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 HeartWare International Pty Ltd Main Business Overview
13.4.5 HeartWare International Pty Ltd Latest Developments
13.5 PulseCath
13.5.1 PulseCath Company Information
13.5.2 PulseCath Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.5.3 PulseCath Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 PulseCath Main Business Overview
13.5.5 PulseCath Latest Developments
13.6 Magenta Medical
13.6.1 Magenta Medical Company Information
13.6.2 Magenta Medical Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.6.3 Magenta Medical Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Magenta Medical Main Business Overview
13.6.5 Magenta Medical Latest Developments
13.7 Shenzhen Hanuo Medical Technology Co., Ltd
13.7.1 Shenzhen Hanuo Medical Technology Co., Ltd Company Information
13.7.2 Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.7.3 Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Shenzhen Hanuo Medical Technology Co., Ltd Main Business Overview
13.7.5 Shenzhen Hanuo Medical Technology Co., Ltd Latest Developments
13.8 Shanghai Newmed Medical Technology Co., Ltd
13.8.1 Shanghai Newmed Medical Technology Co., Ltd Company Information
13.8.2 Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
13.8.3 Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Shanghai Newmed Medical Technology Co., Ltd Main Business Overview
13.8.5 Shanghai Newmed Medical Technology Co., Ltd Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Interventional Ventricular Assist Devices Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Interventional Ventricular Assist Devices Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 2.5L/min
Table 4. Major Players of 3.5L/min
Table 5. Major Players of 5.0L/min
Table 6. Major Players of 5.5L/min
Table 7. Global Interventional Ventricular Assist Devices Sales by Type (2021-2026) & (Units)
Table 8. Global Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
Table 9. Global Interventional Ventricular Assist Devices Revenue by Type (2021-2026) & ($ million)
Table 10. Global Interventional Ventricular Assist Devices Revenue Market Share by Type (2021-2026)
Table 11. Global Interventional Ventricular Assist Devices Sale Price by Type (2021-2026) & (K US$/Unit)
Table 12. Global Interventional Ventricular Assist Devices Sale by Application (2021-2026) & (Units)
Table 13. Global Interventional Ventricular Assist Devices Sale Market Share by Application (2021-2026)
Table 14. Global Interventional Ventricular Assist Devices Revenue by Application (2021-2026) & ($ million)
Table 15. Global Interventional Ventricular Assist Devices Revenue Market Share by Application (2021-2026)
Table 16. Global Interventional Ventricular Assist Devices Sale Price by Application (2021-2026) & (K US$/Unit)
Table 17. Global Interventional Ventricular Assist Devices Sales by Company (2021-2026) & (Units)
Table 18. Global Interventional Ventricular Assist Devices Sales Market Share by Company (2021-2026)
Table 19. Global Interventional Ventricular Assist Devices Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Interventional Ventricular Assist Devices Revenue Market Share by Company (2021-2026)
Table 21. Global Interventional Ventricular Assist Devices Sale Price by Company (2021-2026) & (K US$/Unit)
Table 22. Key Manufacturers Interventional Ventricular Assist Devices Producing Area Distribution and Sales Area
Table 23. Players Interventional Ventricular Assist Devices Products Offered
Table 24. Interventional Ventricular Assist Devices Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Interventional Ventricular Assist Devices Sales by Geographic Region (2021-2026) & (Units)
Table 28. Global Interventional Ventricular Assist Devices Sales Market Share Geographic Region (2021-2026)
Table 29. Global Interventional Ventricular Assist Devices Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Interventional Ventricular Assist Devices Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Interventional Ventricular Assist Devices Sales by Country/Region (2021-2026) & (Units)
Table 32. Global Interventional Ventricular Assist Devices Sales Market Share by Country/Region (2021-2026)
Table 33. Global Interventional Ventricular Assist Devices Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Interventional Ventricular Assist Devices Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Interventional Ventricular Assist Devices Sales by Country (2021-2026) & (Units)
Table 36. Americas Interventional Ventricular Assist Devices Sales Market Share by Country (2021-2026)
Table 37. Americas Interventional Ventricular Assist Devices Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Interventional Ventricular Assist Devices Sales by Type (2021-2026) & (Units)
Table 39. Americas Interventional Ventricular Assist Devices Sales by Application (2021-2026) & (Units)
Table 40. APAC Interventional Ventricular Assist Devices Sales by Region (2021-2026) & (Units)
Table 41. APAC Interventional Ventricular Assist Devices Sales Market Share by Region (2021-2026)
Table 42. APAC Interventional Ventricular Assist Devices Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Interventional Ventricular Assist Devices Sales by Type (2021-2026) & (Units)
Table 44. APAC Interventional Ventricular Assist Devices Sales by Application (2021-2026) & (Units)
Table 45. Europe Interventional Ventricular Assist Devices Sales by Country (2021-2026) & (Units)
Table 46. Europe Interventional Ventricular Assist Devices Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Interventional Ventricular Assist Devices Sales by Type (2021-2026) & (Units)
Table 48. Europe Interventional Ventricular Assist Devices Sales by Application (2021-2026) & (Units)
Table 49. Middle East & Africa Interventional Ventricular Assist Devices Sales by Country (2021-2026) & (Units)
Table 50. Middle East & Africa Interventional Ventricular Assist Devices Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Interventional Ventricular Assist Devices Sales by Type (2021-2026) & (Units)
Table 52. Middle East & Africa Interventional Ventricular Assist Devices Sales by Application (2021-2026) & (Units)
Table 53. Key Market Drivers & Growth Opportunities of Interventional Ventricular Assist Devices
Table 54. Key Market Challenges & Risks of Interventional Ventricular Assist Devices
Table 55. Key Industry Trends of Interventional Ventricular Assist Devices
Table 56. Interventional Ventricular Assist Devices Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Interventional Ventricular Assist Devices Distributors List
Table 59. Interventional Ventricular Assist Devices Customer List
Table 60. Global Interventional Ventricular Assist Devices Sales Forecast by Region (2027-2032) & (Units)
Table 61. Global Interventional Ventricular Assist Devices Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Interventional Ventricular Assist Devices Sales Forecast by Country (2027-2032) & (Units)
Table 63. Americas Interventional Ventricular Assist Devices Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Interventional Ventricular Assist Devices Sales Forecast by Region (2027-2032) & (Units)
Table 65. APAC Interventional Ventricular Assist Devices Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Interventional Ventricular Assist Devices Sales Forecast by Country (2027-2032) & (Units)
Table 67. Europe Interventional Ventricular Assist Devices Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Interventional Ventricular Assist Devices Sales Forecast by Country (2027-2032) & (Units)
Table 69. Middle East & Africa Interventional Ventricular Assist Devices Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Interventional Ventricular Assist Devices Sales Forecast by Type (2027-2032) & (Units)
Table 71. Global Interventional Ventricular Assist Devices Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Interventional Ventricular Assist Devices Sales Forecast by Application (2027-2032) & (Units)
Table 73. Global Interventional Ventricular Assist Devices Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Abiomed, Inc. Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 75. Abiomed, Inc. Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 76. Abiomed, Inc. Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 77. Abiomed, Inc. Main Business
Table 78. Abiomed, Inc. Latest Developments
Table 79. LivaNova, Inc Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 80. LivaNova, Inc Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 81. LivaNova, Inc Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 82. LivaNova, Inc Main Business
Table 83. LivaNova, Inc Latest Developments
Table 84. Levitronix Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 85. Levitronix Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 86. Levitronix Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 87. Levitronix Main Business
Table 88. Levitronix Latest Developments
Table 89. HeartWare International Pty Ltd Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 90. HeartWare International Pty Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 91. HeartWare International Pty Ltd Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 92. HeartWare International Pty Ltd Main Business
Table 93. HeartWare International Pty Ltd Latest Developments
Table 94. PulseCath Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 95. PulseCath Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 96. PulseCath Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 97. PulseCath Main Business
Table 98. PulseCath Latest Developments
Table 99. Magenta Medical Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 100. Magenta Medical Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 101. Magenta Medical Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 102. Magenta Medical Main Business
Table 103. Magenta Medical Latest Developments
Table 104. Shenzhen Hanuo Medical Technology Co., Ltd Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 105. Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 106. Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 107. Shenzhen Hanuo Medical Technology Co., Ltd Main Business
Table 108. Shenzhen Hanuo Medical Technology Co., Ltd Latest Developments
Table 109. Shanghai Newmed Medical Technology Co., Ltd Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 111. Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 112. Shanghai Newmed Medical Technology Co., Ltd Main Business
Table 113. Shanghai Newmed Medical Technology Co., Ltd Latest Developments
Table 1. Interventional Ventricular Assist Devices Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Interventional Ventricular Assist Devices Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of 2.5L/min
Table 4. Major Players of 3.5L/min
Table 5. Major Players of 5.0L/min
Table 6. Major Players of 5.5L/min
Table 7. Global Interventional Ventricular Assist Devices Sales by Type (2021-2026) & (Units)
Table 8. Global Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
Table 9. Global Interventional Ventricular Assist Devices Revenue by Type (2021-2026) & ($ million)
Table 10. Global Interventional Ventricular Assist Devices Revenue Market Share by Type (2021-2026)
Table 11. Global Interventional Ventricular Assist Devices Sale Price by Type (2021-2026) & (K US$/Unit)
Table 12. Global Interventional Ventricular Assist Devices Sale by Application (2021-2026) & (Units)
Table 13. Global Interventional Ventricular Assist Devices Sale Market Share by Application (2021-2026)
Table 14. Global Interventional Ventricular Assist Devices Revenue by Application (2021-2026) & ($ million)
Table 15. Global Interventional Ventricular Assist Devices Revenue Market Share by Application (2021-2026)
Table 16. Global Interventional Ventricular Assist Devices Sale Price by Application (2021-2026) & (K US$/Unit)
Table 17. Global Interventional Ventricular Assist Devices Sales by Company (2021-2026) & (Units)
Table 18. Global Interventional Ventricular Assist Devices Sales Market Share by Company (2021-2026)
Table 19. Global Interventional Ventricular Assist Devices Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Interventional Ventricular Assist Devices Revenue Market Share by Company (2021-2026)
Table 21. Global Interventional Ventricular Assist Devices Sale Price by Company (2021-2026) & (K US$/Unit)
Table 22. Key Manufacturers Interventional Ventricular Assist Devices Producing Area Distribution and Sales Area
Table 23. Players Interventional Ventricular Assist Devices Products Offered
Table 24. Interventional Ventricular Assist Devices Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Interventional Ventricular Assist Devices Sales by Geographic Region (2021-2026) & (Units)
Table 28. Global Interventional Ventricular Assist Devices Sales Market Share Geographic Region (2021-2026)
Table 29. Global Interventional Ventricular Assist Devices Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Interventional Ventricular Assist Devices Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Interventional Ventricular Assist Devices Sales by Country/Region (2021-2026) & (Units)
Table 32. Global Interventional Ventricular Assist Devices Sales Market Share by Country/Region (2021-2026)
Table 33. Global Interventional Ventricular Assist Devices Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Interventional Ventricular Assist Devices Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Interventional Ventricular Assist Devices Sales by Country (2021-2026) & (Units)
Table 36. Americas Interventional Ventricular Assist Devices Sales Market Share by Country (2021-2026)
Table 37. Americas Interventional Ventricular Assist Devices Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Interventional Ventricular Assist Devices Sales by Type (2021-2026) & (Units)
Table 39. Americas Interventional Ventricular Assist Devices Sales by Application (2021-2026) & (Units)
Table 40. APAC Interventional Ventricular Assist Devices Sales by Region (2021-2026) & (Units)
Table 41. APAC Interventional Ventricular Assist Devices Sales Market Share by Region (2021-2026)
Table 42. APAC Interventional Ventricular Assist Devices Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Interventional Ventricular Assist Devices Sales by Type (2021-2026) & (Units)
Table 44. APAC Interventional Ventricular Assist Devices Sales by Application (2021-2026) & (Units)
Table 45. Europe Interventional Ventricular Assist Devices Sales by Country (2021-2026) & (Units)
Table 46. Europe Interventional Ventricular Assist Devices Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Interventional Ventricular Assist Devices Sales by Type (2021-2026) & (Units)
Table 48. Europe Interventional Ventricular Assist Devices Sales by Application (2021-2026) & (Units)
Table 49. Middle East & Africa Interventional Ventricular Assist Devices Sales by Country (2021-2026) & (Units)
Table 50. Middle East & Africa Interventional Ventricular Assist Devices Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Interventional Ventricular Assist Devices Sales by Type (2021-2026) & (Units)
Table 52. Middle East & Africa Interventional Ventricular Assist Devices Sales by Application (2021-2026) & (Units)
Table 53. Key Market Drivers & Growth Opportunities of Interventional Ventricular Assist Devices
Table 54. Key Market Challenges & Risks of Interventional Ventricular Assist Devices
Table 55. Key Industry Trends of Interventional Ventricular Assist Devices
Table 56. Interventional Ventricular Assist Devices Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Interventional Ventricular Assist Devices Distributors List
Table 59. Interventional Ventricular Assist Devices Customer List
Table 60. Global Interventional Ventricular Assist Devices Sales Forecast by Region (2027-2032) & (Units)
Table 61. Global Interventional Ventricular Assist Devices Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Interventional Ventricular Assist Devices Sales Forecast by Country (2027-2032) & (Units)
Table 63. Americas Interventional Ventricular Assist Devices Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Interventional Ventricular Assist Devices Sales Forecast by Region (2027-2032) & (Units)
Table 65. APAC Interventional Ventricular Assist Devices Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Interventional Ventricular Assist Devices Sales Forecast by Country (2027-2032) & (Units)
Table 67. Europe Interventional Ventricular Assist Devices Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Interventional Ventricular Assist Devices Sales Forecast by Country (2027-2032) & (Units)
Table 69. Middle East & Africa Interventional Ventricular Assist Devices Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Interventional Ventricular Assist Devices Sales Forecast by Type (2027-2032) & (Units)
Table 71. Global Interventional Ventricular Assist Devices Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Interventional Ventricular Assist Devices Sales Forecast by Application (2027-2032) & (Units)
Table 73. Global Interventional Ventricular Assist Devices Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Abiomed, Inc. Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 75. Abiomed, Inc. Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 76. Abiomed, Inc. Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 77. Abiomed, Inc. Main Business
Table 78. Abiomed, Inc. Latest Developments
Table 79. LivaNova, Inc Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 80. LivaNova, Inc Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 81. LivaNova, Inc Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 82. LivaNova, Inc Main Business
Table 83. LivaNova, Inc Latest Developments
Table 84. Levitronix Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 85. Levitronix Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 86. Levitronix Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 87. Levitronix Main Business
Table 88. Levitronix Latest Developments
Table 89. HeartWare International Pty Ltd Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 90. HeartWare International Pty Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 91. HeartWare International Pty Ltd Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 92. HeartWare International Pty Ltd Main Business
Table 93. HeartWare International Pty Ltd Latest Developments
Table 94. PulseCath Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 95. PulseCath Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 96. PulseCath Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 97. PulseCath Main Business
Table 98. PulseCath Latest Developments
Table 99. Magenta Medical Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 100. Magenta Medical Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 101. Magenta Medical Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 102. Magenta Medical Main Business
Table 103. Magenta Medical Latest Developments
Table 104. Shenzhen Hanuo Medical Technology Co., Ltd Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 105. Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 106. Shenzhen Hanuo Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 107. Shenzhen Hanuo Medical Technology Co., Ltd Main Business
Table 108. Shenzhen Hanuo Medical Technology Co., Ltd Latest Developments
Table 109. Shanghai Newmed Medical Technology Co., Ltd Basic Information, Interventional Ventricular Assist Devices Manufacturing Base, Sales Area and Its Competitors
Table 110. Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Product Portfolios and Specifications
Table 111. Shanghai Newmed Medical Technology Co., Ltd Interventional Ventricular Assist Devices Sales (Units), Revenue ($ Million), Price (K US$/Unit) and Gross Margin (2021-2026)
Table 112. Shanghai Newmed Medical Technology Co., Ltd Main Business
Table 113. Shanghai Newmed Medical Technology Co., Ltd Latest Developments
LIST OF FIGURES
Figure 1. Picture of Interventional Ventricular Assist Devices
Figure 2. Interventional Ventricular Assist Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Interventional Ventricular Assist Devices Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Interventional Ventricular Assist Devices Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Interventional Ventricular Assist Devices Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Interventional Ventricular Assist Devices Sales Market Share by Country/Region (2025)
Figure 10. Interventional Ventricular Assist Devices Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 2.5L/min
Figure 12. Product Picture of 3.5L/min
Figure 13. Product Picture of 5.0L/min
Figure 14. Product Picture of 5.5L/min
Figure 15. Global Interventional Ventricular Assist Devices Sales Market Share by Type in 2026
Figure 16. Global Interventional Ventricular Assist Devices Revenue Market Share by Type (2021-2026)
Figure 17. Interventional Ventricular Assist Devices Consumed in Public Hospitals
Figure 18. Global Interventional Ventricular Assist Devices Market: Public Hospitals (2021-2026) & (Units)
Figure 19. Interventional Ventricular Assist Devices Consumed in Private Hospital
Figure 20. Global Interventional Ventricular Assist Devices Market: Private Hospital (2021-2026) & (Units)
Figure 21. Global Interventional Ventricular Assist Devices Sale Market Share by Application (2025)
Figure 22. Global Interventional Ventricular Assist Devices Revenue Market Share by Application in 2026
Figure 23. Interventional Ventricular Assist Devices Sales by Company in 2026 (Units)
Figure 24. Global Interventional Ventricular Assist Devices Sales Market Share by Company in 2026
Figure 25. Interventional Ventricular Assist Devices Revenue by Company in 2026 ($ millions)
Figure 26. Global Interventional Ventricular Assist Devices Revenue Market Share by Company in 2026
Figure 27. Global Interventional Ventricular Assist Devices Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Interventional Ventricular Assist Devices Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Interventional Ventricular Assist Devices Sales 2021-2026 (Units)
Figure 30. Americas Interventional Ventricular Assist Devices Revenue 2021-2026 ($ millions)
Figure 31. APAC Interventional Ventricular Assist Devices Sales 2021-2026 (Units)
Figure 32. APAC Interventional Ventricular Assist Devices Revenue 2021-2026 ($ millions)
Figure 33. Europe Interventional Ventricular Assist Devices Sales 2021-2026 (Units)
Figure 34. Europe Interventional Ventricular Assist Devices Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Interventional Ventricular Assist Devices Sales 2021-2026 (Units)
Figure 36. Middle East & Africa Interventional Ventricular Assist Devices Revenue 2021-2026 ($ millions)
Figure 37. Americas Interventional Ventricular Assist Devices Sales Market Share by Country in 2026
Figure 38. Americas Interventional Ventricular Assist Devices Revenue Market Share by Country (2021-2026)
Figure 39. Americas Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
Figure 40. Americas Interventional Ventricular Assist Devices Sales Market Share by Application (2021-2026)
Figure 41. United States Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Interventional Ventricular Assist Devices Sales Market Share by Region in 2026
Figure 46. APAC Interventional Ventricular Assist Devices Revenue Market Share by Region (2021-2026)
Figure 47. APAC Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
Figure 48. APAC Interventional Ventricular Assist Devices Sales Market Share by Application (2021-2026)
Figure 49. China Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 53. India Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Interventional Ventricular Assist Devices Sales Market Share by Country in 2026
Figure 57. Europe Interventional Ventricular Assist Devices Revenue Market Share by Country (2021-2026)
Figure 58. Europe Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
Figure 59. Europe Interventional Ventricular Assist Devices Sales Market Share by Application (2021-2026)
Figure 60. Germany Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 61. France Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Interventional Ventricular Assist Devices Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Interventional Ventricular Assist Devices Sales Market Share by Application (2021-2026)
Figure 68. Egypt Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Interventional Ventricular Assist Devices in 2026
Figure 74. Manufacturing Process Analysis of Interventional Ventricular Assist Devices
Figure 75. Industry Chain Structure of Interventional Ventricular Assist Devices
Figure 76. Channels of Distribution
Figure 77. Global Interventional Ventricular Assist Devices Sales Market Forecast by Region (2027-2032)
Figure 78. Global Interventional Ventricular Assist Devices Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Interventional Ventricular Assist Devices Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Interventional Ventricular Assist Devices Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Interventional Ventricular Assist Devices Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Interventional Ventricular Assist Devices Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Interventional Ventricular Assist Devices
Figure 2. Interventional Ventricular Assist Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Interventional Ventricular Assist Devices Sales Growth Rate 2021-2032 (Units)
Figure 7. Global Interventional Ventricular Assist Devices Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Interventional Ventricular Assist Devices Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Interventional Ventricular Assist Devices Sales Market Share by Country/Region (2025)
Figure 10. Interventional Ventricular Assist Devices Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of 2.5L/min
Figure 12. Product Picture of 3.5L/min
Figure 13. Product Picture of 5.0L/min
Figure 14. Product Picture of 5.5L/min
Figure 15. Global Interventional Ventricular Assist Devices Sales Market Share by Type in 2026
Figure 16. Global Interventional Ventricular Assist Devices Revenue Market Share by Type (2021-2026)
Figure 17. Interventional Ventricular Assist Devices Consumed in Public Hospitals
Figure 18. Global Interventional Ventricular Assist Devices Market: Public Hospitals (2021-2026) & (Units)
Figure 19. Interventional Ventricular Assist Devices Consumed in Private Hospital
Figure 20. Global Interventional Ventricular Assist Devices Market: Private Hospital (2021-2026) & (Units)
Figure 21. Global Interventional Ventricular Assist Devices Sale Market Share by Application (2025)
Figure 22. Global Interventional Ventricular Assist Devices Revenue Market Share by Application in 2026
Figure 23. Interventional Ventricular Assist Devices Sales by Company in 2026 (Units)
Figure 24. Global Interventional Ventricular Assist Devices Sales Market Share by Company in 2026
Figure 25. Interventional Ventricular Assist Devices Revenue by Company in 2026 ($ millions)
Figure 26. Global Interventional Ventricular Assist Devices Revenue Market Share by Company in 2026
Figure 27. Global Interventional Ventricular Assist Devices Sales Market Share by Geographic Region (2021-2026)
Figure 28. Global Interventional Ventricular Assist Devices Revenue Market Share by Geographic Region in 2026
Figure 29. Americas Interventional Ventricular Assist Devices Sales 2021-2026 (Units)
Figure 30. Americas Interventional Ventricular Assist Devices Revenue 2021-2026 ($ millions)
Figure 31. APAC Interventional Ventricular Assist Devices Sales 2021-2026 (Units)
Figure 32. APAC Interventional Ventricular Assist Devices Revenue 2021-2026 ($ millions)
Figure 33. Europe Interventional Ventricular Assist Devices Sales 2021-2026 (Units)
Figure 34. Europe Interventional Ventricular Assist Devices Revenue 2021-2026 ($ millions)
Figure 35. Middle East & Africa Interventional Ventricular Assist Devices Sales 2021-2026 (Units)
Figure 36. Middle East & Africa Interventional Ventricular Assist Devices Revenue 2021-2026 ($ millions)
Figure 37. Americas Interventional Ventricular Assist Devices Sales Market Share by Country in 2026
Figure 38. Americas Interventional Ventricular Assist Devices Revenue Market Share by Country (2021-2026)
Figure 39. Americas Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
Figure 40. Americas Interventional Ventricular Assist Devices Sales Market Share by Application (2021-2026)
Figure 41. United States Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 42. Canada Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 43. Mexico Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 44. Brazil Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 45. APAC Interventional Ventricular Assist Devices Sales Market Share by Region in 2026
Figure 46. APAC Interventional Ventricular Assist Devices Revenue Market Share by Region (2021-2026)
Figure 47. APAC Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
Figure 48. APAC Interventional Ventricular Assist Devices Sales Market Share by Application (2021-2026)
Figure 49. China Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 50. Japan Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 51. South Korea Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 52. Southeast Asia Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 53. India Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 54. Australia Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 55. China Taiwan Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 56. Europe Interventional Ventricular Assist Devices Sales Market Share by Country in 2026
Figure 57. Europe Interventional Ventricular Assist Devices Revenue Market Share by Country (2021-2026)
Figure 58. Europe Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
Figure 59. Europe Interventional Ventricular Assist Devices Sales Market Share by Application (2021-2026)
Figure 60. Germany Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 61. France Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 62. UK Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 63. Italy Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 64. Russia Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 65. Middle East & Africa Interventional Ventricular Assist Devices Sales Market Share by Country (2021-2026)
Figure 66. Middle East & Africa Interventional Ventricular Assist Devices Sales Market Share by Type (2021-2026)
Figure 67. Middle East & Africa Interventional Ventricular Assist Devices Sales Market Share by Application (2021-2026)
Figure 68. Egypt Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 69. South Africa Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 70. Israel Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 71. Turkey Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 72. GCC Countries Interventional Ventricular Assist Devices Revenue Growth 2021-2026 ($ millions)
Figure 73. Manufacturing Cost Structure Analysis of Interventional Ventricular Assist Devices in 2026
Figure 74. Manufacturing Process Analysis of Interventional Ventricular Assist Devices
Figure 75. Industry Chain Structure of Interventional Ventricular Assist Devices
Figure 76. Channels of Distribution
Figure 77. Global Interventional Ventricular Assist Devices Sales Market Forecast by Region (2027-2032)
Figure 78. Global Interventional Ventricular Assist Devices Revenue Market Share Forecast by Region (2027-2032)
Figure 79. Global Interventional Ventricular Assist Devices Sales Market Share Forecast by Type (2027-2032)
Figure 80. Global Interventional Ventricular Assist Devices Revenue Market Share Forecast by Type (2027-2032)
Figure 81. Global Interventional Ventricular Assist Devices Sales Market Share Forecast by Application (2027-2032)
Figure 82. Global Interventional Ventricular Assist Devices Revenue Market Share Forecast by Application (2027-2032)
